Company Filing History:

10 out of 1,858

Takeda Chemical Industries, Inc.

patents

7 out of 1,177

Takeda Pharmaceutical Company Limited

patents

Years Active: 1979-2016

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9346822 - Thienopyrimidine compounds and use thereof (2016-05-24),

2. 8883788 - Fused heterocyclic ring compound (2014-11-11),

3. 8735401 - Thienopyrimidine compounds and use thereof (2014-05-27),

4. 8058280 - Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof (2011-11-15),

5. 7569570 - Thienopyrimidines, process for preparing the same and use thereof (2009-08-04),

6. 7300935 - Thienopyrimidine compounds and use thereof (2007-11-27),

7. 7141598 - Imidazole derivatives, production method thereof and use thereof (2006-11-28),

8. 6716863 - Heterocyclic compounds their production and use (2004-04-06),

9. 5539113 - Pyrrolopyrimidine derivatives, their production (1996-07-23),

10. 5496946 - Production of pyrrolopyrimidines and intermediates therefor (1996-03-05),

11. 5496822 - Compounds and methods for treating tumors (1996-03-05),

12. 5354754 - Pyrrolopyrimidines, their production and use (1994-10-11),

13. 5349064 - Production of pyrrolopyrimidines (1994-09-20),

14. 5296600 - Pyrrolopyrimidine derivatives, their production and use (1994-03-22),

15. 5106974 - Pyrrolopyrimidine derivatives (1992-04-21),

Title: Innovations of Takenori Hitaka

Introduction

Takenori Hitaka is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 17 patents. His work primarily focuses on the development of innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents is a series of thienopyrimidine compounds, which are designed to exhibit gonadotropin-releasing hormone antagonistic activity. These compounds are represented by a specific formula, where various substituents can be included to enhance their efficacy. Another notable patent involves a fused heterocyclic ring compound that demonstrates PDE10A inhibitory action, making it useful as a medicament for the prophylaxis or treatment of mental diseases such as schizophrenia.

Career Highlights

Throughout his career, Takenori Hitaka has worked with esteemed organizations such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these companies has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues, including Hiroshi Akimoto and Tetsuo Miwa, to advance his research and innovations in the field.

Conclusion

Takenori Hitaka's contributions to pharmaceutical innovations through his patents and collaborations highlight his significant role in advancing medical science. His work continues to impact the development of new therapeutic options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.